Renal cell carcinoma with retroperitoneal lymph nodes: Role of lymph node dissection

Allan J. Pantuck, Amnon Zisman, Fredrick Dorey, Debby H. Chao, Ken Ryu Han, Jonathan Said, Barbara J. Gitlitz, Robert A. Figlin, Arie S. Belldegrun

Research output: Contribution to journalArticlepeer-review


Purpose: We better defined the benefits and morbidity of lymph node dissection in patients with localized renal cell carcinoma using the experience of patients treated at our institution. Materials and Methods: A retrospective cohort study was performed with outcome assessment based on the chart review of demographic, clinical and pathological data in 1,087 patients with renal cell carcinoma treated at our institution. Patients with renal cell carcinoma who did not undergo nephrectomy as part of cancer treatment, those with bilateral disease and those for whom nodal status was unknown were not included in this study. A total of 900 patients meeting these criteria who underwent nephrectomy for unilateral renal cell carcinoma at our medical center form the principal study population. Results: Positive lymph nodes were associated with larger, higher grade, locally advanced primary tumors that were more commonly associated with sarcomatoid features. Positive nodes were 3 to 4 times more common in patients with metastatic disease and the majority of these patients could be identified preoperatively. The survival of patients with regional lymph node involvement only was identical to that of patients with distant metastatic disease only. Patients with regional nodes and distant metastases had significantly inferior survival to those with either condition alone. In node negative cases lymph node dissection can be performed with no additional morbidity but it confers no survival advantage. In node positive cases lymph node dissection can also be performed safely but it is associated with improved survival and a trend toward an improved response to immunotherapy. Conclusions: Regional lymph node dissection is unnecessary in patients with clinically negative lymph nodes since it offers extremely limited staging information and no benefit in terms of decreasing disease recurrence or improving survival. In patients with positive lymph nodes lymph node dissection is associated with improved survival when it is performed in carefully selected patients undergoing cytoreductive nephrectomy and postoperative immunotherapy. When lymph nodes are present, they should be resected when technically feasible.

Original languageEnglish
Pages (from-to)2076-2083
Number of pages8
JournalJournal of Urology
Issue number6
StatePublished - 1 Jun 2003
Externally publishedYes


  • Carcinoma, renal cell
  • Immunotherapy
  • Kidney
  • Lymph node dissection
  • Survival


Dive into the research topics of 'Renal cell carcinoma with retroperitoneal lymph nodes: Role of lymph node dissection'. Together they form a unique fingerprint.

Cite this